Royal Fund Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-4
Closed -$6K 587
2017
Q4
$6K Buy
+4
New +$6K ﹤0.01% 445